Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
about
MicroRNA expression in human omental and subcutaneous adipose tissueNampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzymeAdipocytokines in renal transplant recipientsMetabolic syndrome in rheumatoid arthritisInflammation and metabolic dysfunction: links to cardiovascular diseasesAdipokines - removing road blocks to obesity and diabetes therapyRegulation of cell survival and death by pyridine nucleotidesEndocrine and Metabolic Effects of Adipose Tissue in Children and AdolescentsA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesVisfatin: a new player in mesangial cell physiology and diabetic nephropathyThe obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammationA role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.The metabolic syndromeObesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Visfatin induces sickness responses in the brain.Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation.Genetic and evolutionary analyses of the human bone morphogenetic protein receptor 2 (BMPR2) in the pathophysiology of obesity.Study of Visfatin Level in Type 1 Diabetic Children and AdolescentsVisfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.Inflammation, a link between obesity and cardiovascular diseaseVisfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.Relationship between blood peroxidases activity and visfatin levels in metabolic syndrome patientsMaternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetesChanges in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment.Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions.Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Metabolic effects of obesity: A reviewIs PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans.Vascular biology of metabolic syndromeAdipocytokines: The pied pipers.Pre-B-cell colony-enhancing factor and its clinical correlates with acute lung injury and sepsis.ADCY5 gene expression in adipose tissue is related to obesity in men and mice.The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes.Serum visfatin and fetuin-a levels and glycemic control in patients with obese type 2 diabetes mellitus.Nicotinamide Phosphoribosyltransferase in Human Diseases.The role of visfatin in diabetic nephropathy
P2860
Q21562476-B4DCDD51-CE50-4CDD-A088-82504439742BQ24299618-CD8833F6-AE7C-42D0-BA4B-46A8831983A5Q26747604-F2AE4657-684F-448A-BA1F-EC954AFC01E8Q26822038-15436242-690A-4ECF-8875-F9347D6FC981Q26851186-55D73EEA-1092-4115-AB34-C0A1E405F775Q26995825-E0F99F62-68B5-489D-904A-6D1F9940F505Q27026075-E8073D9A-838A-43C8-A147-F6F82FCB2301Q28082438-EBC75BB2-9630-4519-9E21-96D83F1FB51EQ28083355-E7154532-8AA4-4411-9159-7654BC4DA1D8Q28577873-36A102A8-240D-4497-9F14-EA277D07ACA4Q28834050-0F1DF1DB-2FB6-4C6A-9500-708299FA2FC6Q30384899-3B079DF3-8522-4827-B978-2983DCAF9AF6Q33569142-D37DCD14-4266-4408-932D-0BAE3FD02241Q33580624-7493822C-B2AD-40EE-B31E-9D57DAF3E4C3Q33809413-CA4A770F-CF1E-4023-9256-5E576A1AF7BFQ33812357-8909599D-BF23-48AA-8B7D-B4A76BC45E65Q33818062-828C8349-10F2-4D56-B71C-52F05141BDB4Q33889578-7074DB05-57D0-48A8-8BE2-425E92E36511Q33939122-5C997C9E-8512-45C9-B73A-9A9FD02F0317Q33946323-09283AA2-8DF5-4EB9-B71D-D85E95D616EAQ34089724-C95AD93B-B24C-4D40-82A1-CE86E1309FC0Q34235479-03B38DDE-1E79-428E-91E0-44D396775760Q34236254-99EDA5E8-45FB-4D3F-9CB6-2ABF33A58694Q34246872-D787C45F-D689-4013-844E-505B27BAA872Q34325856-893D6B3B-F5A6-4AEC-B9EF-383690C70B0BQ34591803-E96D283B-3B5E-4DA4-B565-E47C79B606C4Q34613425-D6884C8A-40EC-4AED-BF40-6CAE20372CB8Q34768535-151C058E-B12A-44E4-8F69-35D15F3298AAQ34779049-A302C0AB-E7C6-40AA-9934-B9A4FC98F6F3Q34877856-35AB19C5-D10D-414C-B87E-8C8B5398338FQ34993305-D7E63012-7DC7-4EFA-95C9-F6B2C13BA47EQ35013558-3DADB40D-D00E-4366-900B-FACA59ED2BCEQ35106315-9C646C91-1327-42E1-B662-15EA76ADE985Q35125469-53B46E56-2293-4530-A61D-8B193825CF84Q35143052-5E03024A-B194-4C56-AF13-1DBFE83FB13CQ35201794-6CB8D91F-4742-46C7-9465-438CC654073EQ35544822-905FA3F2-563C-4E3A-AF0F-9D375C4D23FDQ35564079-833891B4-40FF-40BC-92AD-67258E06B8DFQ35581515-F7AA6D0C-F28F-4147-A57A-672CE13B251AQ35656272-139AA13B-1731-4D8C-B0D5-4937C30DC114
P2860
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@en
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@nl
type
label
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@en
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@nl
prefLabel
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@en
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@nl
P50
P1433
P1476
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans.
@en
P2093
Janin Berndt
Peter Kovacs
P304
P356
10.2337/DIABETES.54.10.2911
P407
P577
2005-10-01T00:00:00Z